T3	Subject 10 49	a patient with type 2 diabetes mellitus
T5	Treatment 74 135;256 280	the antitumor necrosis factor-alpha blocking agent etanercept previous insulin regimen
T6	Effect 177 200	persistent hypoglycemia
T8	Treat-Disorder 25 49;140 163	type 2 diabetes mellitus severe plaque psoriasis
T9	Drug 125 135	etanercept
T10	Drug 265 272	insulin
